Beyond the hashtags, the latest research does suggest that IBS is more prevalent—affecting 6.1% of people in the U.S.—than ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the armamentarium against RA. Monoclonal antibodies and ...

Naomi Dempsey, MD, discussed developments in the HER2-positive breast cancer space, including personalized approaches, less ...

TNBC patients with pCRs had a 5-year event-free survival (EFS) rate of 92% with the addition of ICIs versus 88% without them.

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

In addition to our full armamentarium of medical devices and emergency management solutions, we've introduced innovative technologies to address the physical and mental wellness of our nation's ...

"I've found over the years that the most useful tool in my armamentarium, besides rest and fluids, is nasal saline, which helps with a lot of things, including to help clear out a lot of ...

We have reached a point of impasse in treatment of preterm infants and many of their illnesses. Many of the problems we see ...

and this therapeutic option should be held in the clinician's armamentarium.

Encouraged by new data, Newron Pharmaceuticals has said it will start a registration study of would-be blockbuster evenamide in treatment-resistant schizophrenia (TRS) later this year. The Italian ...